ALLMedicine™ Arrhythmogenic Right Ventricular Dysplasia Center
Research & Reviews 95 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135158
Journal of Cardiovascular Magnetic Resonance : Official J... Zghaib T, Te Riele ASJM et. al.
May 21st, 2021 - Left ventricular (LV) fibrofatty infiltration in arrhythmogenic right ventricular (RV) dysplasia/cardiomyopathy (ARVD/C) has been reported, however, detailed cardiovascular magnetic resonance (CMR) characteristics and association with outcomes are...
https://doi.org/10.1080/14779072.2021.1917383
Expert Review of Cardiovascular Therapy; Haykal M, Matsumori A et. al.
Apr 17th, 2021 - Hepatitis C virus (HCV) infection is an important cause of a variety of otherwise unexplained heart diseases and myocardial injury. A high prevalence of HCV infection has been noted in patients with hypertrophic cardiomyopathy, dilated cardiomyopa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159691
The Journal of Clinical Investigation; Liang Y, Lyon RC et. al.
Apr 16th, 2021 - Dysregulated protein degradative pathways are increasingly recognized as mediators of human disease. This mechanism may have particular relevance to desmosomal proteins that play critical structural roles in both tissue architecture and cell-cell ...
https://doi.org/10.1007/s10554-021-02221-3 10.1016/j.jacc.2004.01.029 10.1161/01.CIR.0000083725.72693.EA 10.1016/S0735-1097(01)01625-4 10.1016/j.jacc.2007.11.027 10.1161/CIRCEP.110.959957 10.1016/j.hrthm.2015.09.023 10.1161/01.CIR.88.3.915 10.1161/CIRCEP.109.904763 10.1161/CIRCEP.110.960740 10.1161/CIRCEP.111.963066 10.1161/CIRCEP.111.968677 10.1161/01.CIR.103.6.913 10.1016/j.hrthm.2010.09.088 10.1159/000070672 10.1046/j.1540-8167.2004.03429.x 10.1161/01.CIR.94.5.983 10.1016/S0735-1097(97)00332-X 10.1016/S0735-1097(01)01625-4 10.1046/j.1540-8167.2005.40710.x 10.1016/S1547-5271(08)00029-5 10.1111/j.1540-8159.2007.00703.x 10.1093/eurheartj/ehq025 10.1093/eurheartj/ehaa003 10.1161/CIRCULATIONAHA.104.486977 10.1016/S1054-8807(01)00067-9 10.1093/eurheartj/14.5.717 10.1016/j.jacc.2008.11.017 10.1093/europace/euw062 10.1161/CIRCEP.111.974881 10.1161/CIRCEP.111.964635 10.1161/CIRCEP.115.003366 10.1016/j.cardiores.2005.03.005 10.1016/j.yjmcc.2010.07.012 10.1161/01.CIR.100.15.1660 10.1016/S0735-1097(02)02494-4 10.1161/01.CIR.0000118467.53182.D1 10.1016/S0735-1097(02)01888-0 10.1046/j.1542-474X.2003.08106.x 10.1161/01.CIR.0000088781.99943.95 10.1016/j.hrthm.2016.12.001 10.1016/j.hrthm.2018.03.019 10.1161/CIRCEP.115.003220 10.1161/CIRCEP.117.005053 10.1016/j.hrthm.2016.07.025 10.1161/CIRCEP.119.007500 10.1161/CIRCULATIONAHA.119.042423 10.1093/europace/euz167 10.1002/joa3.12308 10.1093/europace/euy304 10.1007/s12265-008-9080-7 10.1016/j.jacc.2008.05.038 10.1016/j.jacc.2008.11.052
The International Journal of Cardiovascular Imaging; Zoppo F, Gagno G et. al.
Mar 25th, 2021 - Three-dimensional (3D) reconstruction by means of electroanatomic mapping (EAM) systems, allows for the understanding of the mechanism of focal or re-entrant arrhythmic circuits along with pacing techniques. However, besides this conventional use,...
https://doi.org/10.1161/CIRCEP.119.008307
Circulation. Arrhythmia and Electrophysiology; Okubo K, Gigli L et. al.
Jul 14th, 2020 - In patients with an ischemic cardiomyopathy (ICM), the combination of late potential (LP) abolition and postprocedural ventricular tachycardia (VT) noninducibility is known to be the desirable end point for a successful long-term outcome after VT ...
Guidelines 1 results
https://doi.org/10.1016/j.cardfail.2009.01.006
Journal of Cardiac Failure; Hershberger RE, Lindenfeld J et. al.
Mar 4th, 2009 - Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/ca...
News 7 results
https://www.medscape.com/viewarticle/868501
Sep 7th, 2016 - ROME, ITALY — Most cases of sudden cardiac death in a pathology-registry study of people with hypertrophic cardiomyopathy (HCM) occurred during rest or sleep, not during exercise[1]. Notably, individuals who died on the playing field—mostly on the...
https://www.staging.medscape.com/viewarticle/868501
Sep 7th, 2016 - ROME, ITALY — Most cases of sudden cardiac death in a pathology-registry study of people with hypertrophic cardiomyopathy (HCM) occurred during rest or sleep, not during exercise[1]. Notably, individuals who died on the playing field—mostly on the...
https://www.staging.medscape.com/viewarticle/823062
Apr 3rd, 2014 - WASHINGTON, DC — In the end, it really wasn't much of a debate at all. Two experts, citing similar research, made the case that most athletes with heart problems requiring an implantable cardioverter defibrillator (ICD) should be allowed to partic...
https://www.medscape.com/viewarticle/806917
Jun 26th, 2013 - There's a lot controversy surrounding the relationship between endurance exercise and heart disease. Smart people debate the issue of causality, the dosage of exercise needed to provoke disease, and many other confounding factors. But one thing we...
https://www.medscape.com/viewarticle/801894
Sep 7th, 2012 - This feature requires the newest version of Flash. You can download it here. Dr Samuel Asirvatham joins the show to discuss arrhythmogenic right ventricular dysplasia (ARVD), the second most common cause of death in young athletes after hypertroph...
